Molson Coors Beverage (NYSE:TAP – Get Free Report) is set to release its earnings data before the market opens on Thursday, November 7th. Analysts expect Molson Coors Beverage to post earnings of $1.67 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.
Molson Coors Beverage (NYSE:TAP – Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.68 by $0.24. The company had revenue of $3.25 billion during the quarter, compared to analysts’ expectations of $3.18 billion. Molson Coors Beverage had a return on equity of 9.58% and a net margin of 8.27%. The firm’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the business posted $1.78 EPS. On average, analysts expect Molson Coors Beverage to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.
Molson Coors Beverage Trading Up 1.3 %
TAP opened at $55.71 on Tuesday. The stock has a market cap of $11.54 billion, a PE ratio of 10.20, a PEG ratio of 2.37 and a beta of 0.82. The company has a quick ratio of 0.75, a current ratio of 0.95 and a debt-to-equity ratio of 0.46. The business has a 50 day moving average of $55.25 and a 200-day moving average of $54.52. Molson Coors Beverage has a 52 week low of $49.19 and a 52 week high of $69.18.
Analyst Ratings Changes
Read Our Latest Stock Analysis on Molson Coors Beverage
Molson Coors Beverage Company Profile
Molson Coors Beverage Company manufactures, markets, and sells beer and other malt beverage products under various brands in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers flavored malt beverages including hard seltzers, craft, spirits and energy, and ready to drink beverages.
Recommended Stories
- Five stocks we like better than Molson Coors Beverage
- What is a Death Cross in Stocks?
- Intel: Is Now the Time to Be Brave?Â
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Invest in Biotech Stocks
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Molson Coors Beverage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molson Coors Beverage and related companies with MarketBeat.com's FREE daily email newsletter.